搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Yarrowia lipolytica Autophagy protein 16 (ATG16) CSB-YP731963YAP
CSB-EP731963YAP
CSB-BP731963YAP
CSB-MP731963YAP
CSB-EP731963YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein HIR1 (HIR1), partial CSB-YP731964YAP
CSB-EP731964YAP
CSB-BP731964YAP
CSB-MP731964YAP
CSB-EP731964YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein PBN1 (PBN1), partial CSB-YP731965YAP
CSB-EP731965YAP
CSB-BP731965YAP
CSB-MP731965YAP
CSB-EP731965YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Mediator of RNA polymerase II transcription subunit 21 (SRB7) CSB-YP731966YAP
CSB-EP731966YAP
CSB-BP731966YAP
CSB-MP731966YAP
CSB-EP731966YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Superoxide dismutase [Cu-Zn] (SOD1) CSB-YP731967YAP
CSB-EP731967YAP
CSB-BP731967YAP
CSB-MP731967YAP
CSB-EP731967YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Plasma membrane fusion protein PRM1 (PRM1), partial CSB-YP731968YAP1
CSB-EP731968YAP1
CSB-BP731968YAP1
CSB-MP731968YAP1
CSB-EP731968YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Histone acetyltransferase ESA1 (ESA1) CSB-YP731969YAP
CSB-EP731969YAP
CSB-BP731969YAP
CSB-MP731969YAP
CSB-EP731969YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica mRNA-capping enzyme subunit alpha (CEG1) CSB-YP731970YAP
CSB-EP731970YAP
CSB-BP731970YAP
CSB-MP731970YAP
CSB-EP731970YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Probable kinetochore protein SPC24 (SPC24) CSB-YP731971YAP
CSB-EP731971YAP
CSB-BP731971YAP
CSB-MP731971YAP
CSB-EP731971YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Pre-rRNA-processing protein PNO1 (PNO1) CSB-YP731972YAP
CSB-EP731972YAP
CSB-BP731972YAP
CSB-MP731972YAP
CSB-EP731972YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Palmitoyltransferase PFA4 (PFA4), partial CSB-YP731973YAP1
CSB-EP731973YAP1
CSB-BP731973YAP1
CSB-MP731973YAP1
CSB-EP731973YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Golgi apparatus membrane protein TVP23 (TVP23), partial CSB-YP731974YAP1
CSB-EP731974YAP1
CSB-BP731974YAP1
CSB-MP731974YAP1
CSB-EP731974YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Serine/threonine-protein kinase BUR1 (BUR1), partial CSB-YP731975YAP
CSB-EP731975YAP
CSB-BP731975YAP
CSB-MP731975YAP
CSB-EP731975YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Pre-mRNA-splicing factor CWC22 (CWC22), partial CSB-YP731976YAP
CSB-EP731976YAP
CSB-BP731976YAP
CSB-MP731976YAP
CSB-EP731976YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Cytoplasmic tRNA 2-thiolation protein 1 (NCS6) CSB-YP731977YAP
CSB-EP731977YAP
CSB-BP731977YAP
CSB-MP731977YAP
CSB-EP731977YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica FACT complex subunit SPT16 (SPT16), partial CSB-YP731978YAP
CSB-EP731978YAP
CSB-BP731978YAP
CSB-MP731978YAP
CSB-EP731978YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Potential protein lysine methyltransferase SET5 (SET5) CSB-YP731979YAP
CSB-EP731979YAP
CSB-BP731979YAP
CSB-MP731979YAP
CSB-EP731979YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Protein DSE1 (DSE1), partial CSB-YP731980YAP
CSB-EP731980YAP
CSB-BP731980YAP
CSB-MP731980YAP
CSB-EP731980YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica NEDD8-conjugating enzyme UBC12 (UBC12) CSB-YP731981YAP
CSB-EP731981YAP
CSB-BP731981YAP
CSB-MP731981YAP
CSB-EP731981YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica RNA polymerase II holoenzyme cyclin-like subunit (SSN8) CSB-YP731982YAP
CSB-EP731982YAP
CSB-BP731982YAP
CSB-MP731982YAP
CSB-EP731982YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>